Bausys Augustinas, Senina Veslava, Luksta Martynas, Anglickiene Giedre, Molnikaite Greta, Bausys Bernardas, Rybakovas Andrius, Baltruskeviciene Edita, Laurinavicius Arvydas, Poskus Tomas, Bausys Rimantas, Seinin Dmitrij, Strupas Kestutis
Clinic of Gastroenterology, Nephrourology, and Surgery, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
National Centre of Pathology, Affiliate of Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
J Cancer. 2021 Jan 16;12(6):1669-1677. doi: 10.7150/jca.49673. eCollection 2021.
The study aims to evaluate the lymph node (LN) response to preoperative chemotherapy and its impact on long-term outcomes in advanced gastric cancer (AGC). Histological specimens retrieved at gastrectomy from patients who received preoperative chemotherapy were evaluated. LN regression was graded by the adapted tumor regression grading system proposed by Becker. Patients were classified as node-negative (lnNEG) in the case of all negative LN without evidence of previous tumor involvement. Patients with LN metastasis were classified as nodal responders (lnR) in case of a regression score 1a-2 was detected in the LN. Nodal non-responders (lnNR) had a regression score of 3 in all of the metastatic nodes. Survival was compared using Kaplan-Meier and Cox regression analysis. Among 87 patients included in the final analysis 29.9 % were lnNEG, 21.8 % were lnR and 48.3 % were lnNR. Kaplan-Meier curves showed a survival benefit for lnR over lnNR (p=0.03), while the survival of lnR and lnNEG patients was similar. Cox regression confirmed nodal response to be associated with decreased odds for death in univariate (HR: 0.33; 95 % CI 0.11-0.96, p=0.04) and multivariable (HR 0.37; 95 CI% 0.14-0.99, p=0.04) analysis. Histologic regression of LN metastasis after preoperative chemotherapy predicts the increased survival of patients with non-metastatic resectable AGC.
本研究旨在评估晚期胃癌(AGC)患者术前化疗后淋巴结(LN)的反应及其对长期预后的影响。对接受术前化疗的患者在胃切除术中获取的组织学标本进行评估。根据Becker提出的改良肿瘤消退分级系统对LN消退进行分级。若所有LN均为阴性且无先前肿瘤累及的证据,则将患者分类为淋巴结阴性(lnNEG)。若在LN中检测到消退评分1a - 2,则将有LN转移的患者分类为淋巴结反应者(lnR)。淋巴结无反应者(lnNR)在所有转移淋巴结中的消退评分为3。使用Kaplan - Meier法和Cox回归分析比较生存率。在纳入最终分析的87例患者中,29.9%为lnNEG,21.8%为lnR,48.3%为lnNR。Kaplan - Meier曲线显示lnR患者的生存率优于lnNR患者(p = 0.03),而lnR和lnNEG患者的生存率相似。Cox回归证实,在单因素分析(HR:0.33;95%CI 0.11 - 0.96,p = 0.04)和多因素分析(HR 0.37;95%CI 0.14 - 0.99,p = 0.04)中,淋巴结反应与死亡几率降低相关。术前化疗后LN转移的组织学消退可预测非转移性可切除AGC患者生存率的提高。